Drug Trial Radar · NCT00651261
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
717
Actual
Start
Apr 2008
Primary completion
Jul 2016
Study completion Mar 28, 2022
Sponsor
- Lead sponsor
- Alliance for Clinical Trials in OncologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI); Novartis Pharmaceuticals
- First posted
- Apr 2, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 59 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effects, good and/or bad, of a standard chemotherapy regimen for AML that includes the drugs daunorubicin and cytarabine combined with or without midostaurin (also known as PKC412), to find out which is better. This research is being done because it is unknown whether the addition of midostaurin to chemotherapy treatment is better than chemotherapy treatment alone. Midostaurin has been tested in over 400 patients and is being studied in a number of illnesses, including AML, colon cancer, and lung cancer. Midostaurin blocks an enzyme, produced by a gene known as FLT3, that may have a role in the survival and growth of AML cells. Not all leukemia cells will have the abnormal FLT3 gene. This study will focus only on patients with leukemia cells with the abnormal FLT3 gene.
Conditions
- Leukemia
Interventions
cytarabineDrug
Given IV
daunorubicinDrug
Given IV
midostaurinDrug
Given orally
placeboOther
Given orally
dexamethasone acetateDrug
ocular medication administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: Duration of study (Up to 10 years)
Locations
176 sites in 2 countries. Site status is shown where the registry gives one.
UAB Comprehensive Cancer Center
Birmingham, Alabama
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas
University of California Davis Cancer Center
Sacramento, California
Aurora Presbyterian Hospital
Aurora, Colorado
Boulder Community Hospital
Boulder, Colorado
Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado
St. Anthony Central Hospital
Denver, Colorado
Porter Adventist Hospital
Denver, Colorado
Presbyterian - St. Luke's Medical Center
Denver, Colorado
St. Joseph Hospital
Denver, Colorado
Rose Medical Center
Denver, Colorado
CCOP - Colorado Cancer Research Program
Denver, Colorado
Swedish Medical Center
Englewood, Colorado
North Colorado Medical Center
Greeley, Colorado
Sky Ridge Medical Center
Lone Tree, Colorado
Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado
McKee Medical Center
Loveland, Colorado
North Suburban Medical Center
Thornton, Colorado
Exempla Lutheran Medical Center
Wheat Ridge, Colorado
Helen and Harry Gray Cancer Center at Hartford Hospital
Hartford, Connecticut
Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware
CCOP - Christiana Care Health Services
Newark, Delaware
University of Florida Shands Cancer Center
Gainesville, Florida
Memorial Cancer Institute at Memorial Regional Hospital
Hollywood, Florida
Baptist Cancer Institute - Jacksonville
Jacksonville, Florida
Florida Hospital Cancer Institute at Florida Hospital Orlando
Orlando, Florida
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida
MBCCOP - Medical College of Georgia Cancer Center
Augusta, Georgia
Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur, Georgia
Medical Center of Central Georgia
Macon, Georgia
Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler
Savannah, Georgia
Cancer Research Center of Hawaii
Honolulu, Hawaii
Queen's Cancer Institute at Queen's Medical Center
Honolulu, Hawaii
Illinois CancerCare - Bloomington
Bloomington, Illinois
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois
University of Illinois Cancer Center
Chicago, Illinois
University of Chicago Cancer Research Center
Chicago, Illinois
Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois
Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois
BroMenn Regional Medical Center
Normal, Illinois
Showing 40 of 176 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.